Electromed (ELMD) EBIT Growth (3y) (2013 - 2026)
Electromed (ELMD) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 13.06% |
| 10 | Electromed | 329.52 Mn | 312.53 Mn | 14.64 Mn | 46.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.57% |
| Dec 31, 2025 | 41.64% |
| Sep 30, 2025 | 292.96% |
| Jun 30, 2025 | 83.13% |
| Mar 31, 2025 | 35.35% |
| Dec 31, 2024 | 33.18% |
| Sep 30, 2024 | 53.29% |
| Jun 30, 2024 | 53.00% |
| Mar 31, 2024 | 96.40% |
| Dec 31, 2023 | 12.65% |
| Sep 30, 2023 | -40.17% |
| Jun 30, 2023 | 5.03% |
| Mar 31, 2023 | 9.41% |
| Dec 31, 2022 | -6.67% |
| Sep 30, 2022 | -68.05% |
| Jun 30, 2022 | -30.72% |
| Mar 31, 2022 | 22.93% |
| Dec 31, 2021 | 16.82% |
| Sep 30, 2021 | 38.68% |
| Jun 30, 2021 | -19.82% |